- ￥2588 - 7788
- abinScience
- France
- HA551023
- 2025年07月11日
- ELISA
- Alpaca
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
\
- 亚型：
VHH-His
- 形态：
Liquid
- 保存条件：
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Human
- 保质期：
1year
- 抗原来源：
Alpaca
- 目录编号：
HA551023
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Alpaca
- 应用范围：
ELISA
- 浓度：
1mg/mL
- 靶点：
CEP164
- 抗体英文名：
Anti-Human CEP164 Nanobody (36Z)
- 抗体名：
Anti-Human CEP164 Nanobody (36Z)
- 规格：
100ug/1mg
| 规格： | 100ug | 产品价格： | ￥2588.0 |
|---|---|---|---|
| 规格： | 1mg | 产品价格： | ￥7788.0 |
| Product name | Anti-Human CEP164 Nanobody (36Z) |
|---|---|
| Catalog No. | HA551023 |
| Form | Liquid |
| Species | Human |
| Clonality | Monoclonal |
| Applications | ELISA |
| Target | CEP164 (Q9UPV0) |
| Alternative Names | Centrosomal protein of 164 kDa, Cep164, CEP164 |
| 品牌 | abinScience |
| Note | For research use only. |
abinScience, founded in 2023 and located in the innovation technology center in Strasbourg, France, is the core research reagent brand of ProteoGenix. Focusing on the development and production of life science research reagents, abinScience takes "Empowering Bioscience Discovery" as its vision, and is committed to providing high-quality and innovative biological reagent products and technical solutions for global researchers.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验erythrocytes to microvascular endothelial cells CD36 deficiency frequent in sub-Saharan Africa, Asia; associated surprisingly with susceptibility to severe cerebral malaria Development of anti-CD36 antibodies can cause serious complications
左旋 DNA 的发现是近年来分子遗传学的重大发现之一。 1972 年 Pohl 等发现人工合成的嘌呤与嘧啶相间排列的多聚核苷酸顺序（ GCGCGC ）在高盐的条件下，旋光性会发生改变。接着王惠君（ Wang A.H.J ）和 A.Rich 对六聚体 d （ CGCGCG ）单晶作了分辩率达 0.09nm 的 X- 衍射分析，提出了 Z-DNA 模型。 Z-DNA 的结构特点： （1） 糖磷骨架量
Immortalization of Human Prostate Cells With the Human Papillomavirus Type 16 E6 Gene
A survey of the Medline titles for the years 2000–2001 revealed 125 papers whose titles included the name of the androgen-sensitive prostate cancer cell line LNCaP, and 36 papers also included PC3, the most common androgen independent line
技术资料暂无技术资料 索取技术资料
